Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Neurobiology of Aging

• Publication date

  1985-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0197-4580(85)90055-7PMID 3903533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Naloxone effects on β-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers

  2004cited by this paper
• Low- and high-dose naloxone in dementia of the Alzheimer type.

  1985cited by this paper
• Oral physostigmine treatment of patients with Alzheimer's disease.

  1985cited by this paper
• Does severity of dementia modulate response to dexamethasone in individuals with primary degenerative dementia?

  1984cited by this paper
• Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain

  1984cited by this paper
• Effects of naloxone in senile dementia: a double-blind trial.

  1983cited by this paper
• Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease.

  1983cited by this paper
• Behavioural effects of opioid peptides.

  1983cited by this paper
• High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses.

  1983cited by this paper
• Age-dependent changes in the beta-endorphin content of discrete rat brain nuclei.

  1981cited by this paper
• Age-dependent changes in the β-endorphin content of discrete rat brain nuclei

  1981cited by this paper
• Verbal fluency in aging and dementia

  1980cited by this paper
• 3H-Dihydromorphine binding in brain regions of young and aged rats.

  1980cited by this paper
• Naloxone alters locomotion and interaction with environmental stimuli.

  1979cited by this paper
• Naloxone fails to affect short-term memory in man.

  1979cited by this paper
• Naloxone increases ACTH and cortisol levels in man.

  1979cited by this paper
• An analysis of some perceptual effects of morphine, chlorpromazine, and LSD

  1979cited by this paper
• Hormonal and other effects of naltrexone in normal men.

  1979cited by this paper
• Opiate receptor binding in rhesus monkey brain: association with limbic structures.

  1978cited by this paper
• Motor performance after unilateral hemisphere damage in patients with tumor.

  1977cited by this paper
• Naltrexone: Physiological and psychological effects of single doses

  1976cited by this paper
• Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

  1973cited by this paper

• Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses

  2020cites this paper
• Alzheimer's Disease and Autistic Spectrum Disorder: Is there any Association?

  2016cites this paper
• Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.

  2012cites this paper
• Controlled Clinical Trials in Neurological Disease

  2011cites this paper
• A GPCR/secretase complex regulates β- and γ-secretase specificity for Aβ production and contributes to AD pathogenesis

  2010cites this paper
• Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease

  2008cites this paper
• Physiologic and neuroendocrine responses to intravenous naloxone in subjects with Alzheimer's disease and age-matched controls.

  1999cites this paper
• Potential Pharmacologic Agents for the Cognitive Effects of Electroconvulsive Treatment

  1998cites this paper
• Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease

  1994cites this paper
• Neurotransmitter replacement therapy in Alzheimer's disease.

  1994cites this paper
• The pharmacological management of cognitive impairment in the demented patient.

  1993cites this paper
• Pharmacological treatment of the cognitive side effects of ECT: a review.

  1992cites this paper
• Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys.

  1991cites this paper
• Strategies for Treating Alzheimer’s Disease and Age-Associated Memory Impairment

  1989cites this paper
• Naloxone administration impairs autoshaped learning.

  1989cites this paper
• Drug Treatments of Dementia

  1989cites this paper
• Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.

  1988cites this paper
• Cognitive Enhancing Agents: Current Status in the Treatment of Alzheimer's Disease

  1988cites this paper
• Loss of the cortisol response to naltrexone in Alzheimer's disease.

  1988cites this paper
• A Review of Recent Clinical Trials in the Treatment of Alzheimer's Dementia

  1987cites this paper